Elizabeth Tolley, PhD

Scientist, Social and Behavioral Health Sciences

Areas of expertise

  • HIV prevention research
  • HIV in adolescents

Projects & Resources

  • Should ongoing clinical trials identify an effective microbicide, the next challenge will be to ensure product access and use. Communication campaigns will play a critical role in generating demand and encouraging correct use.

  • FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.

Explore More Related to Elizabeth Tolley, PhD